Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Healthy Volunteers

Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Healthy Patient Studies Clinical Trials

A listing of Healthy Patient Studies medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (9) clinical trials

All enrolled subjects must be 18 to 75 years of age. To be enrolled, he or she must also have a history of recurrent herpes labialis (cold sores) and report recurrences during the preceding 12 months. For more information, please visit www.optimalsites.net/coldsore

Phase

A single ascending dose study of the safety and immunogenicity of NasoVAX. An intranasal flu vaccine  

Phase

Doctors at Albert Einstein College of Medicine are seeking healthy volunteers, aged 21-60, to participate in a medical research study to better understand glucose metabolism and brain function. Inclusion Criteria: BP < 130/90 (+-2 meds) BMI < 35 Normal screening labs (CBC, chemistry, lft's PT/PTT) No CAD No first degree ...

Phase

This is a 18 month study with 50 visits to treat subcutaneous fat that is causing central abdominal bulging in non-obese patients.

Phase

The Rodriguez Lab is seeking healthy volunteers to participate in clinical research studies involving the understanding of the brain. We are exploring the function of healthy brain and your participation will help us discover therapies for OCD and Hoarding Disorder. You participation is vital in medical research. The goal of ...

Phase

The Rodriguez Lab is seeking healthy volunteers to participate in clinical research studies evolving the understanding of the brain. We are exploring the function of healthy brain and your participation will help us discover therapies for OCD and Hoarding Disorder. You participation is vital in medical research. The goal of ...

Phase

Dose-Ranging Study to Evaluate the Safety and Immunogenicity of VAL-181388 in Healthy Adults in a Non-endemic Chikungunya Region

Phase

Ruxolitinib (previously known as INCB018424 phosphate, INC424, ruxolitinib phosphate) is a novel, potent, and selective inhibitor of Janus kinase (JAK) 1 and JAK2 with modest to marked selectivity against tyrosine kinase 2 (TYK2) and JAK3, respectively. Ruxolitinib has been granted marketing authorisation approval for the treatment of myelofibrosis (MF) and ...

Phase

Study Description: The purpose of this study is to test whether two investigational drugs called CAD106 and CNP520, administered separately, can slow down the onset and progression of clinical symptoms associated with Alzheimer's disease (AD) in participants at the risk to develop clinical symptoms based on their age and genotype. ...

Phase